Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-05-26 5:09 pm Purchase |
2022-05-16 | 13G | Annexon, Inc. ANNX |
BIOTECHNOLOGY VALUE FUND L P | 3,343,194 8.700% |
3,343,194![]() (New Position) |
Filing History |
2022-05-02 5:02 pm Purchase |
2022-04-22 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 1,929,201 5.400% |
1,929,201![]() (New Position) |
Filing History |
2022-05-02 4:59 pm Purchase |
2022-04-22 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 1,964,859 5.100% |
1,964,300![]() (+351395.35%) |
Filing History |
2022-04-18 4:49 pm Purchase |
2022-04-05 | 13D | MoonLake Immunotherapeutics MLTX |
BIOTECHNOLOGY VALUE FUND L P | 21,751,284 58.900% |
21,751,284![]() (New Position) |
Filing History |
2022-04-04 4:38 pm Purchase |
2022-03-25 | 13G | AN2 Therapeutics, Inc. ANTX |
BIOTECHNOLOGY VALUE FUND L P | 1,616,665 8.600% |
1,616,665![]() (New Position) |
Filing History |
2022-03-24 4:22 pm Purchase |
2022-03-14 | 13G | Tyra Biosciences, Inc. TYRA |
BIOTECHNOLOGY VALUE FUND L P | 2,472,327 5.900% |
2,472,327![]() (New Position) |
Filing History |
2022-03-18 7:18 pm Sale |
2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
BIOTECHNOLOGY VALUE FUND L P | 4,305,540 8.200% |
-851,946![]() (-16.52%) |
Filing History |
2022-03-14 4:48 pm Purchase |
2022-03-03 | 13G | Arcus Biosciences, Inc. RCUS |
BIOTECHNOLOGY VALUE FUND L P | 3,960,948 5.600% |
1,208,726![]() (+43.92%) |
Filing History |
2022-02-14 2:01 pm Sale |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 6,353,645 7.100% |
-2,030,000![]() (-24.21%) |
Filing History |
2022-02-14 1:56 pm Purchase |
2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 92,583 9.990% |
22,563![]() (+32.22%) |
Filing History |
2022-02-14 1:53 pm Purchase |
2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
BIOTECHNOLOGY VALUE FUND L P | 5,157,486 9.990% |
1,658,140![]() (+47.38%) |
Filing History |
2022-02-14 1:51 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
BIOTECHNOLOGY VALUE FUND L P | 2,202,315 9.990% |
2,202,315![]() (New Position) |
Filing History |
2022-02-14 1:49 pm Purchase |
2021-12-31 | 13G | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 511,918 16.500% |
103,724![]() (+25.41%) |
Filing History |
2022-02-14 1:46 pm Purchase |
2021-12-31 | 13G | Elevation Oncology, Inc. ELEV |
BIOTECHNOLOGY VALUE FUND L P | 1,611,698 6.900% |
1,611,698![]() (New Position) |
Filing History |
2022-02-14 1:43 pm Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
BIOTECHNOLOGY VALUE FUND L P | 4,565,242 9.990% |
859,953![]() (+23.21%) |
Filing History |
2022-02-14 1:41 pm Sale |
2021-12-31 | 13G | AC Immune SA ACIU |
BIOTECHNOLOGY VALUE FUND L P | 7,062,379 9.700% |
-854,279![]() (-10.79%) |
Filing History |
2022-02-14 1:38 pm Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
BIOTECHNOLOGY VALUE FUND L P | 3,114,532 7.500% |
282![]() (+0.01%) |
Filing History |
2022-02-14 1:35 pm Purchase |
2021-12-31 | 13G | Ikena Oncology, Inc. IKNA |
BIOTECHNOLOGY VALUE FUND L P | 1,798,371 5.000% |
198,713![]() (+12.42%) |
Filing History |
2022-02-14 1:33 pm Purchase |
2021-12-31 | 13G | Viracta Therapeutics, Inc. VIRX |
BIOTECHNOLOGY VALUE FUND L P | 3,731,744 9.900% |
3,731,744![]() (New Position) |
Filing History |
2022-02-14 1:30 pm Purchase |
2021-12-31 | 13G | Molecular Templates, Inc. MTEM |
BIOTECHNOLOGY VALUE FUND L P | 225,307 6.000% |
41,232![]() (+22.40%) |
Filing History |